Approval · Notice of Compliance 25215 · 2021
POSANOL: Notice of Compliance 25215
Issued February 15, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25215
- Date
- February 15, 2021
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of ana alternative drug product manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| POSANOL | Not yet assigned | — |
Medicinal ingredients
- POSACONAZOLE 18 MG per ML